NYSE · HCA

HCA Healthcare, Inc.

$382.19 +$5.69 (+1.51%) 1D After hours
Charting by TradingView

Key Metrics

$83.52B
Market cap
12.29×
P/E · TTM
$76.39B
Revenue · TTM
$6.79B
Net income
EPS · TTM $27.24
Dividend yield 0.8%
Free cash flow $7.93B
Beta · 1Y 0.18
EBITDA · TTM $13.39B
Gross margin —

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 8
    From its Mar 9 high, the share price fell 34%.

    Peak close $545.13 on Mar 9; trough close $361.32 on Jun 8. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -34%
  • Apr 24
    The stock moved -8.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 24

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$83.52B
Enterprise value$130.22B
Shares outstanding221.8M
52-wk range$331.61 – $556.52
Avg volume · 20D1.4M
Net cash −$46.70B
Book value / share$-25.27
IndustryServices-General Medical & Surgical Hospitals, Nec
ExchangeNYSE
About HCA Healthcare, Inc.
IPO dateMar 10, 2011
Employees320000

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E12.29
P/S1.09
P/FCF10.54
EV/EBITDA9.73
EV/Sales1.70
Graham №—

Profitability

Gross —
Operating 12.8%
Net 8.9%
FCF 10.4%
ROE / ROIC -154.4% · 19.2%

Financial Health

Current ratio0.83
Quick ratio0.75
Debt / equity-7.62
Debt / EBITDA 3.59
Net cash −$46.70B
Working capital−$3.21B

Cash Flow · TTM

Operating CF $13.00B
Capex −$5.07B
Free cash flow $7.93B
Buybacks $9.13B
Dividends paid $682.00M
Shareholder yield 11.8%

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

—
Insufficient balance-sheet inputs

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings